ERCC1 Cys8092Ala and XRCC1 Arg399Gln polymorphisms predict progression-free survival after curative radiotherapy for nasopharyngeal carcinoma
about
The polymorphism of CYP2E1 Rsa I/Pst I gene and susceptibility to respiratory system cancer: a systematic review and meta-analysis of 34 studies.Pharmacogenomics in Pediatric Oncology: Review of Gene-Drug Associations for Clinical UseCommon polymorphisms of the hOGG1, APE1 and XRCC1 genes correlate with the susceptibility and clinicopathological features of primary angle-closure glaucomaA five-variable signature predicts radioresistance and prognosis in nasopharyngeal carcinoma patients receiving radical radiotherapy.Clinical utility of plasma Epstein-Barr virus DNA and ERCC1 single nucleotide polymorphism in nasopharyngeal carcinoma.Genetic polymorphisms of long non-coding RNA GAS5 predict platinum-based concurrent chemoradiotherapy response in nasopharyngeal carcinoma patientsThe impacts of genetic polymorphisms in genes of base excision repair pathway on the efficacy and acute toxicities of (chemo)radiotherapy in patients with nasopharyngeal carcinoma.
P2860
Q27691809-7CA458B5-A92E-4915-BF9F-07F060837A37Q28068930-E8803EF0-BFDA-46D1-9914-6C7D17DF4B7EQ33815820-BD599D0D-C915-47A3-944F-56247B9A452AQ41308391-48AC2DD8-A3A3-4B51-80E8-BBBB2260FEE3Q41758054-0745FCB8-AEB3-48B9-A285-627E994DB7FFQ42365336-4C518E78-4B06-4B51-9EEF-1C50ADCF2AB9Q46140928-246A39E4-8FFC-4DDE-ACE3-06B9F3183A0D
P2860
ERCC1 Cys8092Ala and XRCC1 Arg399Gln polymorphisms predict progression-free survival after curative radiotherapy for nasopharyngeal carcinoma
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
ERCC1 Cys8092Ala and XRCC1 Arg ...... y for nasopharyngeal carcinoma
@ast
ERCC1 Cys8092Ala and XRCC1 Arg ...... y for nasopharyngeal carcinoma
@en
ERCC1 Cys8092Ala and XRCC1 Arg ...... y for nasopharyngeal carcinoma
@nl
type
label
ERCC1 Cys8092Ala and XRCC1 Arg ...... y for nasopharyngeal carcinoma
@ast
ERCC1 Cys8092Ala and XRCC1 Arg ...... y for nasopharyngeal carcinoma
@en
ERCC1 Cys8092Ala and XRCC1 Arg ...... y for nasopharyngeal carcinoma
@nl
prefLabel
ERCC1 Cys8092Ala and XRCC1 Arg ...... y for nasopharyngeal carcinoma
@ast
ERCC1 Cys8092Ala and XRCC1 Arg ...... y for nasopharyngeal carcinoma
@en
ERCC1 Cys8092Ala and XRCC1 Arg ...... y for nasopharyngeal carcinoma
@nl
P2093
P2860
P3181
P1433
P1476
ERCC1 Cys8092Ala and XRCC1 Arg ...... y for nasopharyngeal carcinoma
@en
P2093
Bingqiang Hu
Jingtian Tang
Jumei Zhou
Xiaoxue Xie
Yingying Zhang
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0101256
P407
P577
2014-01-01T00:00:00Z